Tagged as: Novo Nordisk v. Beccera et al.

IRA Drug Price Negotiation Program Litigation Updates – Denial of PI Motion and Motion to Dismiss in Chambers of Commerce Case and New Complaint Filed by Novo Nordisk

Denial of Motion to Dismiss and Motion for Preliminary Injunction in Chambers of Commerce case On Friday, September 29, the court in Dayton Area Chamber of Commerce et al. v. Becerra et al. (S.D. Ohio, Judge Newman) issued the first substantive order addressing legal challenges to the Drug Price Negotiation…

Read More